GDC-0941 , ≥98% , 957054-30-7
CAS NO.:957054-30-7
Empirical Formula: C23H27N7O3S2
Molecular Weight: 513.64
MDL number: MFCD11616196
EINECS: 1312995-182-4
| Pack Size | Price | Stock | Quantity |
| 10MG | RMB355.20 | In Stock |
|
| 50MG | RMB1279.20 | In Stock |
|
| 250MG | RMB3347.20 | In Stock |
|
| others | Enquire |
PRODUCT Properties
| Melting point: | >200oC (dec.) |
| Density | 1.53±0.1 g/cm3(Predicted) |
| storage temp. | -20°C |
| solubility | Soluble in DMSO (>25 mg/ml) |
| pka | 12.22±0.40(Predicted) |
| form | White powder solid. |
| color | White/off-white |
| Stability: | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months. |
| InChIKey | LHNIIDJUOCFXAP-UHFFFAOYSA-N |
| SMILES | C1(C2=CC=CC3=C2C=NN3)=NC(N2CCOCC2)=C2SC(CN3CCN(S(C)(=O)=O)CC3)=CC2=N1 |
Description and Uses
GDC-0941/Pictilisib (957054-30-7) is a potent and selective inhibitor of class I phosphatidylinositol-3-kinases (PI3K) with significant antitumor activity – IC50’s: PI3Kα = 3nM, PI3Kβ = 33 nM, PI3Kδ = 3 nM, PI3Kγ = 75 nM.1,2?? GDC-0941 is the chemical probe of choice for the pan-inhibition of class I PI3K’s.3?Currently in clinical trials.4
GDC-0941 is a potent and selective oral inhibitor of the class I PI3K. GDC-0941 demonstrated broad spectrum of activity in breast, ovarian, lung, and prostate cancer models. Studies has also shown GDC-0941 may enhance anti-tumor activity of Docetaxel (D494420) in human breast cancer models. Potent PI3K inhibitor.
Safety
| Symbol(GHS) | ![]() GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P280-P301+P312-P302+P352-P305+P351+P338 |
| HS Code | 29350090 |







